{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:17:32Z","timestamp":1792034252737,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460254"],"award-info":[{"award-number":["82460254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060236"],"award-info":[{"award-number":["82060236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2026.107009","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:44:41Z","timestamp":1768520681000},"page":"107009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of blood-brain barrier integrity and clinical characteristics in autoimmune glial fibrillary acidic protein astrocytopathy"],"prefix":"10.1016","volume":"107","author":[{"given":"Yanlan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianting","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-9873","authenticated-orcid":false,"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107009_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1519700","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review[J]","volume":"16","author":"Bai","year":"2025","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.msard.2026.107009_bib0018","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","article-title":"Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases[J]","volume":"252","author":"Brettschneider","year":"2005","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2026.107009_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051461","article-title":"Cerebrospinal fluid-basic concepts review[J]","volume":"11","author":"Czarniak","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2026.107009_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231164806","article-title":"Clinical and electrophysiological characteristics of peripheral neuropathy in autoimmune glial fibrillary acidic protein astrocytopathy: an observational study and literature review[J]","volume":"16","author":"Deng","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"11","key":"10.1016\/j.msard.2026.107009_bib0001","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis[J]","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107009_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients[J]","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107009_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-023-02678-7","article-title":"New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis[J]","volume":"147","author":"Guo","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.msard.2026.107009_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16284","article-title":"Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: a systematic review and meta-analysis[J]","volume":"31","author":"Hagbohm","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2026.107009_bib0013","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/atm-19-330","article-title":"Detection and significance of glial fibrillary acidic protein antibody in autoimmune astocytopathy and related diseases[J]","volume":"11","author":"Huang","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"Pt B","key":"10.1016\/j.msard.2026.107009_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury[J]","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.msard.2026.107009_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1375971","article-title":"Clinical characteristics and MRI features of autoimmune glial fibrillary acidic protein astrocytopathy: a case series of 34 patients[J]","volume":"15","author":"Ke","year":"2024","journal-title":"Front Neurol."},{"key":"10.1016\/j.msard.2026.107009_bib0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy[J]","volume":"332","author":"Kimura","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.msard.2026.107009_bib0028","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s13760-023-02268-0","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: clinical analysis and review of 15 cases[J]","volume":"123","author":"Lan","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.msard.2026.107009_bib0007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review[J]","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.msard.2026.107009_bib0039","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/cns.14336","article-title":"Epstein-Barr virus: to be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?[J]","volume":"29","author":"Li","year":"2023","journal-title":"CNS. Neurosci. Ther."},{"key":"10.1016\/j.msard.2026.107009_bib0029","article-title":"Review of clinical and imaging findings in autoimmune glial fibrillary acidic protein astrocytopathy to aid in early diagnosis[J]","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.msard.2026.107009_bib0035","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2169\/internalmedicine.8964-21","article-title":"Repeated brain magnetic resonance imaging provides clues for the diagnosis of autoimmune glial fibrillary acid protein astrocytopathy[J]","volume":"61","author":"Natori","year":"2022","journal-title":"Intern Med."},{"key":"10.1016\/j.msard.2026.107009_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2024.08.009","article-title":"What we've learnt about autoimmune neurological diseases from neuropathology[J]","author":"Nitsch","year":"2024","journal-title":"Rev. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2026.107009_bib0016","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/BRS.0000000000002295","article-title":"Immediate versus delayed surgical treatment of lumbar disc herniation for acute motor deficits: the impact of surgical timing on functional outcome[J]","volume":"44","author":"Petr","year":"2019","journal-title":"Spine"},{"key":"10.1016\/j.msard.2026.107009_bib0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijid.2022.09.029","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy masquerading as tuberculosis of the central nervous system: a case series[J]","volume":"124","author":"Quek","year":"2022","journal-title":"Int. J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.msard.2026.107009_bib0012","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1007\/s00415-021-10479-9","article-title":"Cerebrospinal fluid analysis in Guillain-Barr\u00e9 syndrome: value of albumin quotients[J]","volume":"268","author":"Rath","year":"2021","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107009_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases[J]","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107009_bib0024","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature[J]","volume":"9","author":"Shan","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107009_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12974-020-01810-8","article-title":"Immuno-metabolic impact of the multiple sclerosis patients' sera on endothelial cells of the blood-brain barrier[J]","volume":"17","author":"Sheikh","year":"2020","journal-title":"J. Neuroinflammat."},{"issue":"19","key":"10.1016\/j.msard.2026.107009_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910625","article-title":"Blood-brain barrier disruption in neuroimmunological disease[J]","volume":"25","author":"Shimizu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107009_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/25785826.2018.1531190","article-title":"Blood-brain barrier dysfunction in immuno-mediated neurological diseases[J]","volume":"41","author":"Shimizu","year":"2018","journal-title":"Immunol Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107009_bib0033","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/aian.AIAN_334_20","article-title":"Clinical features, gender differences, disease course, and outcome in Neuromyelitis Optica spectrum disorder[J]","volume":"24","author":"Singh","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.msard.2026.107009_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction[J]","volume":"15","author":"Takata","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.msard.2026.107009_bib0019","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-d-aspartate receptor-encephalitis[J]","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.msard.2026.107009_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107009_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577718","article-title":"Clinical, neuroradiological, diagnostic, and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: a pooled analysis of 324 cases from published data and a single-center retrospective study[J]","volume":"360","author":"Xiao","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107009_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104057","article-title":"Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD, and AQP4-IgG+ NMOSD mimicking intracranial infection as the initial manifestation[J]","volume":"66","author":"Xiao","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107009_bib0014","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2018.00251","article-title":"Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies[J]","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107009_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102350","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy mimics infectious meningitis: two case reports[J]","volume":"45","author":"Yang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107009_bib0008","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1038\/s41598-025-91438-6","article-title":"Clinical and pathological risk factors for postencephalitic epilepsy after herpes simplex virus-1 encephalitis in children[J]","volume":"15","author":"Yin","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107009_bib0026","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.msard.2018.10.114","article-title":"Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients[J]","volume":"27","author":"You","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107009_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102604","article-title":"The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity[J]","volume":"47","author":"Yu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107009_bib0023","article-title":"Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients[J]","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2026.107009_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70102","article-title":"A comparative study of 141 glial fibrillary acidic protein immunoglobulin G positive cases[J]","volume":"32","author":"Zhang","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107009_bib0002","article-title":"Clinical, imaging features and outcomes of patients with anti-GFAP antibodies: a retrospective study[J]","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:53:39Z","timestamp":1780415619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S2211034826000453"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107009","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of blood-brain barrier integrity and clinical characteristics in autoimmune glial fibrillary acidic protein astrocytopathy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107009"}}